Brief: Cue Biopharma Reports Fourth Quarter Results
21/03/2023 20:12
March 21 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
* QTRLY LOSS PER SHARE $0.37
* Q4 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX41P50Z
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))